349 related articles for article (PubMed ID: 25298733)
1. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.
Aydemir Y; Aydemir Ö; Kalem F
Int J Chron Obstruct Pulmon Dis; 2014; 9():1045-51. PubMed ID: 25298733
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
3. Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.
Bafadhel M; Haldar K; Barker B; Patel H; Mistry V; Barer MR; Pavord ID; Brightling CE
Int J Chron Obstruct Pulmon Dis; 2015; 10():1075-83. PubMed ID: 26089657
[TBL] [Abstract][Full Text] [Related]
4. Sputum microbiology predicts health status in COPD.
Braeken DC; Houben-Wilke S; Smid DE; Rohde GG; Drijkoningen JJ; Wouters EF; Spruit MA; Franssen FM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2741-2748. PubMed ID: 27853361
[TBL] [Abstract][Full Text] [Related]
5. Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD.
Boixeda R; Almagro P; Díez-Manglano J; Cabrera FJ; Recio J; Martin-Garrido I; Soriano JB
Int J Chron Obstruct Pulmon Dis; 2015; 10():2581-91. PubMed ID: 26664106
[TBL] [Abstract][Full Text] [Related]
6. Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test.
Dai MY; Qiao JP; Xu YH; Fei GH
Int J Chron Obstruct Pulmon Dis; 2015; 10():2257-63. PubMed ID: 26527871
[TBL] [Abstract][Full Text] [Related]
7. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
[TBL] [Abstract][Full Text] [Related]
8. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations.
Calderazzo MA; Trujillo-Torralbo MB; Finney LJ; Singanayagam A; Bakhsoliani E; Padmanaban V; Kebadze T; Aniscenko J; Elkin SL; Johnston SL; Mallia P
Int J Chron Obstruct Pulmon Dis; 2019; 14():823-832. PubMed ID: 31114182
[No Abstract] [Full Text] [Related]
10. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
11. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
[TBL] [Abstract][Full Text] [Related]
13. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
[TBL] [Abstract][Full Text] [Related]
14. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
15. Association between lung function and exacerbation frequency in patients with COPD.
Hoogendoorn M; Feenstra TL; Hoogenveen RT; Al M; Mölken MR
Int J Chron Obstruct Pulmon Dis; 2010 Dec; 5():435-44. PubMed ID: 21191438
[TBL] [Abstract][Full Text] [Related]
16. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
17. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
[TBL] [Abstract][Full Text] [Related]
18. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
[TBL] [Abstract][Full Text] [Related]
19. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.
Mackay AJ; Donaldson GC; Patel AR; Jones PW; Hurst JR; Wedzicha JA
Am J Respir Crit Care Med; 2012 Jun; 185(11):1218-24. PubMed ID: 22281834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
